Axiom Bio
Axiom is a company that eliminates drug toxicity by providing scientists with AI models that are more accurate and affordable than traditional physical experiments. Their key product is an AI-driven liver toxicity prediction model that uses the world's largest human liver dataset combined with advanced machine learning techniques to predict clinical liver injury with higher accuracy and lower cost. This approach helps reduce drug development failures due to toxicity, saving millions in synthesis and assay costs and avoiding late-stage clinical trial failures. Axiom's technology is positioned as a modern alternative to animal testing, aligning with regulatory shifts away from animal experiments. Their platform offers precise clinical risk assessment and data visualization tools, serving large pharmaceutical companies as early partners.
Axiom Bio
Axiom is a company that eliminates drug toxicity by providing scientists with AI models that are more accurate and affordable than traditional physical experiments. Their key product is an AI-driven liver toxicity prediction model that uses the world's largest human liver dataset combined with advanced machine learning techniques to predict clinical liver injury with higher accuracy and lower cost. This approach helps reduce drug development failures due to toxicity, saving millions in synthesis and assay costs and avoiding late-stage clinical trial failures. Axiom's technology is positioned as a modern alternative to animal testing, aligning with regulatory shifts away from animal experiments. Their platform offers precise clinical risk assessment and data visualization tools, serving large pharmaceutical companies as early partners.